...
首页> 外文期刊>Current infectious disease reports. >Molecular diagnosis of viral respiratory infections.
【24h】

Molecular diagnosis of viral respiratory infections.

机译:病毒性呼吸道感染的分子诊断。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In clinical practice, a rapid and accurate identification of pathogens causing viral respiratory tract infections can be problematic because of nonspecific clinical presentations, lack of rapid and sensitive tests, and the emergence of new and mutating viral pathogens. Nucleic acid-targeted molecular techniques are increasingly being used to provide high sensitivity and specificity, short test turnaround time, and automatic and high-throughput processing. In-house and commercially available molecular methods have been developed to qualitatively and quantitatively detect and identify a single or a panel of clinically encountered respiratory tract viruses in a single reaction. Molecular techniques are being gradually introduced in routine laboratory diagnosis of viral respiratory tract infections. However, their performance characteristics and limitations must be clearly understood by both laboratory personnel and clinicians to ensure proper utilization and interpretation.
机译:在临床实践中,由于非特异性临床表现,缺乏快速灵敏的检测方法以及新的和变异的病毒病原体的出现,对导致病毒性呼吸道感染的病原体进行快速,准确的鉴定可能会遇到问题。以核酸为目标的分子技术正越来越多地用于提供高灵敏度和特异性,较短的测试周转时间以及自动和高通量处理。已开发出内部和可商购的分子方法,以在单个反应中定性和定量检测和鉴定单个或一组临床遇到的呼吸道病毒。分子技术正在病毒性呼吸道感染的常规实验室诊断中逐步引入。但是,实验室人员和临床医生必须清楚地了解其性能特征和局限性,以确保正确使用和解释。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号